Hochschulschrift
Development of therapeutic strategies for the treatment of cardiac fibrosis and diastolic dysfunction
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
30 cm
- Umfang
-
IV, 147 Blätter
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen, Diagramme
Enthält 2 Zeitschriftenaufsätze
Hannover Medical School, Dissertation, 2017
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 13:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Entstanden
- September 2017
Ähnliche Objekte (12)
Dapagliflozin attenuates diabetes-induced diastolic dysfunction and cardiac fibrosis by regulating SGK1 signaling
Diastolic dysfunction and diastolic heart failure: diagnostic, prognostic and therapeutic aspects
Reducing RBM20 activity improves diastolic dysfunction and cardiac atrophy
Early diastolic filling dynamics in diastolic dysfunction
Cardiac function during weaning failure: the role of diastolic dysfunction
Diastolic dysfunction is common and predicts outcome after cardiac surgery
Identification of long noncoding RNA targets for the treatment of cardiac fibrosis and diastolic dysfunction in heart failure
Pathophysiology and therapeutic potential of cardiac fibrosis
Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetes
Myofilament dysfunction in diastolic heart failure
Inhibition of the cardiac fibroblast-enriched histone methyltransferase Dot1L prevents cardiac fibrosis and cardiac dysfunction
Atrial delayed enhancement is associated with the severity of diastolic dysfunction in cardiac amyloidosis
Dapagliflozin attenuates diabetes-induced diastolic dysfunction and cardiac fibrosis by regulating SGK1 signaling
Diastolic dysfunction and diastolic heart failure: diagnostic, prognostic and therapeutic aspects
Reducing RBM20 activity improves diastolic dysfunction and cardiac atrophy
Early diastolic filling dynamics in diastolic dysfunction
Cardiac function during weaning failure: the role of diastolic dysfunction
Diastolic dysfunction is common and predicts outcome after cardiac surgery
Identification of long noncoding RNA targets for the treatment of cardiac fibrosis and diastolic dysfunction in heart failure
Pathophysiology and therapeutic potential of cardiac fibrosis
Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetes
Myofilament dysfunction in diastolic heart failure
Inhibition of the cardiac fibroblast-enriched histone methyltransferase Dot1L prevents cardiac fibrosis and cardiac dysfunction
Atrial delayed enhancement is associated with the severity of diastolic dysfunction in cardiac amyloidosis
Dapagliflozin attenuates diabetes-induced diastolic dysfunction and cardiac fibrosis by regulating SGK1 signaling
Diastolic dysfunction and diastolic heart failure: diagnostic, prognostic and therapeutic aspects
Reducing RBM20 activity improves diastolic dysfunction and cardiac atrophy
Early diastolic filling dynamics in diastolic dysfunction
Cardiac function during weaning failure: the role of diastolic dysfunction
Diastolic dysfunction is common and predicts outcome after cardiac surgery
Identification of long noncoding RNA targets for the treatment of cardiac fibrosis and diastolic dysfunction in heart failure
Pathophysiology and therapeutic potential of cardiac fibrosis
Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetes
Myofilament dysfunction in diastolic heart failure
Inhibition of the cardiac fibroblast-enriched histone methyltransferase Dot1L prevents cardiac fibrosis and cardiac dysfunction